CalReduce Mint By Life Extension Overview & Drug Interactions
Check For Interactions With CalReduce Mint
Supplement: CalReduce Mint by Life Extension
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Calories
Ingredient Group | Header |
---|---|
Category | other |
-
Dietary Fiber
Ingredient Group Fiber (unspecified) Category fiber
Total Carbohydrates
Ingredient Group | Carbohydrate |
---|---|
Category | sugar |
FBCx Alpha Cyclodextrin
Ingredient Group | Alpha-cyclodextrin |
---|---|
Category | fiber |
Drugs that interact with CalReduce Mint by Life Extension
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with CalReduce Mint. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
2 Chewable Tablet(s)
|
Maximum serving Sizes: |
2 Chewable Tablet(s)
|
Servings per container | 60 |
UPC/BARCODE | 737870182313 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Calories |
5 Calorie(s)
|
Header |
|
Total Carbohydrates |
3 Gram(s)
|
Carbohydrate |
1%
|
Dietary Fiber |
2 Gram(s)
|
Fiber (unspecified) |
8%
|
FBCx Alpha Cyclodextrin |
2000 mg
|
Alpha-cyclodextrin |
--
|
Other Ingredients: |
Sorbitol
Xylitol
Stearic Acid
Calcium Silicate
Xanthan Gum
L-Leucine
natural Peppermint flavor
Citric Acid
Stevia
Gum Arabic
|
---|
Label Statments:
General Statements |
- Scan for product info
- This supplement should be taken in conjunction with a healthy diet and regular exercise program. Results may vary.
- Selectively binds unhealthy dietary fats for weight loss enhancement
- To report a serious adverse event or obtain product information, contact 1-866-280-2852.
|
---|---|
General |
- QE01823B
|
Brand IP Statement(s) |
- Read the entire label and follow the directions carefully prior to use.
Directions: Chew two (2) tablets immediately after a fat-containing meal, once or twice daily, or as recommended by a healthcare practitioner. Do not swallow tablets whole.
- FBCx is a trademark of Soho Flordis International Pty Ltd.
|
Precautions |
- Warnings:
Keep out of reach of children.
- - Do not exceed recommended dose.
- Do not purchase if outer seal is broken or damaged.
- When using nutritional supplements, please consult with your physician if you are undergoing treatment for a medical condition or if you are pregnant or lactating.
|
FDA Disclaimer Statement |
- These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
|
FDA Statement of Identity |
- Dietary Supplement
|
Storage |
- Store tightly closed in a cool, dry place.
|
Formulation |
- Selective Fat Binder
|
Brand Information
See all products by this brand
Manufactured for: | |
---|---|
Name | Quality Supplements and Vitamins, Inc. |
City | Ft. Lauderdale |
State | FL |
ZipCode | 33309 |
Phone Number | 866-280-2852 |
[email protected] | |
Web Address | www.lef.org |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.